203 related articles for article (PubMed ID: 23292073)
41. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
42. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
[TBL] [Abstract][Full Text] [Related]
43. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy.
Xu LF; Sun HL; Chen YT; Ni JY; Chen D; Luo JH; Zhou JX; Hu RM; Tan QY
J Gastroenterol Hepatol; 2013 Mar; 28(3):456-63. PubMed ID: 23216261
[TBL] [Abstract][Full Text] [Related]
44. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.
Kim JH; Won HJ; Shin YM; Kim SH; Yoon HK; Sung KB; Kim PN
Ann Surg Oncol; 2011 Jun; 18(6):1624-9. PubMed ID: 21445671
[TBL] [Abstract][Full Text] [Related]
45. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Qi X; Liu L; Wang D; Li H; Su C; Guo X
Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation.
Wang X; Liang H; Lu Z
Minim Invasive Ther Allied Technol; 2020 Dec; 29(6):344-352. PubMed ID: 31375044
[No Abstract] [Full Text] [Related]
47. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
48. Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma.
Li W; Ni CF
Abdom Radiol (NY); 2019 Jun; 44(6):2268-2275. PubMed ID: 31016345
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
Zheng L; Li HL; Guo CY; Luo SX
Korean J Radiol; 2018; 19(2):237-246. PubMed ID: 29520181
[TBL] [Abstract][Full Text] [Related]
50. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
[TBL] [Abstract][Full Text] [Related]
51. A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma.
Li X; Dai D; Song X; Liu J; Zhu L; Xu W
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):583-91. PubMed ID: 24924902
[TBL] [Abstract][Full Text] [Related]
52. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.
Gui CH; Baey S; D'cruz RT; Shelat VG
Eur J Surg Oncol; 2020 May; 46(5):763-771. PubMed ID: 31937433
[TBL] [Abstract][Full Text] [Related]
53. Radiofrequency ablation vs radiation therapy vs transarterial chemoembolization vs yttrium 90 for local treatment of liver cancer - a systematic review and network meta-analysis of survival data.
Chow R; Simone CB; Jairam MP; Swaminath A; Boldt G; Lock M
Acta Oncol; 2022 Apr; 61(4):484-494. PubMed ID: 34846988
[TBL] [Abstract][Full Text] [Related]
54. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
[TBL] [Abstract][Full Text] [Related]
55. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma.
Endo K; Kuroda H; Oikawa T; Okada Y; Fujiwara Y; Abe T; Sato H; Sawara K; Takikawa Y
Scand J Gastroenterol; 2018 Dec; 53(12):1575-1583. PubMed ID: 30577723
[TBL] [Abstract][Full Text] [Related]
57. Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study.
Yan L; Ren Y; Qian K; Kan X; Zhang H; Chen L; Liang B; Zheng C
BMC Gastroenterol; 2021 Apr; 21(1):182. PubMed ID: 33879085
[TBL] [Abstract][Full Text] [Related]
58. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.
Peng ZW; Zhang YJ; Chen MS; Xu L; Liang HH; Lin XJ; Guo RP; Zhang YQ; Lau WY
J Clin Oncol; 2013 Feb; 31(4):426-32. PubMed ID: 23269991
[TBL] [Abstract][Full Text] [Related]
59. Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study.
Wang Y; Ma L; Yuan Z; Zheng J; Li W
PLoS One; 2018; 13(7):e0201525. PubMed ID: 30063737
[TBL] [Abstract][Full Text] [Related]
60. Thalidomide Combined with Transcatheter Arterial Chemoembolization (TACE) for Intermediate or Advanced Hepatocellular Carcinoma: A Systematic Review and GRADE Approach.
Yang W; Wang D; Huang L; Chen Y; Wen S; Hong Q; Kang D
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2043-2055. PubMed ID: 30139041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
